Stock Snapshot
Price Performance
Recommendation Rationale
Favorable growth outlook supported by geographical expansion and product innovation.
Basis of our Recommendation
BLISSGVS is positioning itself for long-term growth through geographical expansion, particularly in Sub-Saharan Africa, and product diversification. The company is enhancing its manufacturing capabilities to meet rising global demand. However, it faces risks from regulatory challenges and geopolitical tensions that could impact its operations.
Why We Like This Stock
- Expansion into Sub-Saharan Africa with new operations in Kenya
- Diversification of product portfolio through innovation
- Scaling manufacturing capabilities to meet global demand
Things To Watch Out For
- Evolving regulatory challenges
- Geopolitical tensions impacting supply chains
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 770 | 810 | 927 | 946 | 985 |
| Profit Before Tax (Cr.) | 146 | 126 | 192 | 189 | 199 |
| PBT Margin | 19.0% | 15.6% | 20.7% | 20.0% | 20.2% |
| Net Profit (Cr.) | 105 | 85 | 124 | 135 | 142 |
| EPS | 9.3 | 7.5 | 11.1 | 12.7 | 13.4 |
Company Overview
Show Company Profile
Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotion, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, shampoo, soaps, sprays, and vaginal washes. In addition, it offers therapeutic products consisting of analgesics, antacids, anxiolytics, and haematinics; anti-bacterials, antibiotics, anti-diabetics, anti-diarrheals, anti-emetics, antifungals, anti-haemorrhoidals, anti-helmintics, anti-infectives, anti-inflammatories, anti-malarials, anti-microbials, anti-migraines, anti-oxidants, anti-protozoals, anti-pyretics, anti-septics, anti-spasmodics, anti-ulcers, and anti-ulcerants; cough syrups and nasal decongestants; and products for erectile dysfunction, laryngitis, and pharyngitis. Further, it provides and anti-dandruff shampoos, appetizers, hand sanitizers, health and nutritional supplements, insecticides, mosquito repellants, moisturizers, prickly heat powders, skin lightening lotions, vaginal contraceptives, vaginal hygiene products, and vitamin supplements; and amino acid preparations, iron tonics, antitussives, appetite stimulants, anti-allergics, body supplements, ear wax solvents, and oral rehydration products. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.